HCC ClinicalImpact: Expert Tools and Guidance to Apply the Results of Practice-Changing Clinical Research to Patient Care

Download All
Get expert insights into optimal care of patients with advanced HCC with expert commentaries, an interactive text module, downloadable slides, a treatment algorithm and toxicity resource, and an interactive treatment decision support tool.
Richard S. Finn, MD
Program Director
Richard S. Finn, MD
Lipika Goyal, MD
Amit G. Singal, MD, MS
Mark Yarchoan, MD
Thomas A. Abrams, MD
Amit G. Singal, MD, MS
Mark Yarchoan, MD
Andrew X. Zhu, MD, PhD, FACP

ClinicalThought

With atezolizumab plus bevacizumab becoming a standard of care for first-line systemic treatment of patients with advanced HCC, second-line therapy for these patients has become more challenging. In this commentary, expert faculty discuss treatment options in this setting.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: October 1, 2020

With this commentary, review expert discussion of key studies in HCC presented as ASCO GI 2021, with a focus on potentially practice-changing data.

Mark Yarchoan, MD Released: February 11, 2021

Module

In this interactive module, expert faculty use a case-based approach to discuss contemporary management of patients with advanced HCC.

Richard S. Finn, MD
Program Director
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: October 29, 2020 Expired: No longer available for credit

Downloadable Slideset

Download this slideset for expert perspectives on best practices and emerging strategies in the treatment of patients with advanced HCC.

Richard S. Finn, MD Released: October 29, 2020

Treatment Algorithm and Toxicity Management Resource

Download this clinical resource PDF reviewing best practices in the management of patients with advanced hepatocellular carcinoma.

Released: October 30, 2020

Interactive Decision Support Tool

Use this Interactive Decision Support Tool to compare your choices of therapy for patients with advanced HCC with those of 5 renowned experts.

Richard S. Finn, MD
Program Director
Thomas A. Abrams, MD Amit G. Singal, MD, MS Mark Yarchoan, MD Andrew X. Zhu, MD, PhD, FACP
Released: March 31, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
Genentech, a member of the Roche Group
Lilly

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings